The global cell processing instruments market size is anticipated to reach USD 9.74 billion by 2030 and is projected to grow at a CAGR of 7.04% from 2024-2030, according to a new report by Grand View Research, Inc. The rising incidence of chronic diseases, continuous advancements in cell processing technologies, and the expanding field of stem cell research are anticipated to increase the demand for cell processing instruments over the forecast period.
The COVID-19 pandemic has had a positive impact on the market growth. The pandemic has impelled investments in biopharmaceutical research, including cell-based therapies, driving demand for cell processing instruments. In addition, the increased demand for vaccines and treatments has accelerated the adoption of advanced cell processing technologies, boosting market growth. Moreover, it also highlighted the importance of regenerative medicine and cell therapies in addressing healthcare challenges, further driving interest and investment in this sector.
Moreover, continuous advancements in cell processing technologies, such as automated systems, closed systems, and the integration of robotics, improve efficiency, reduce contamination risks, and enhance the scalability of cell processing, thus driving market growth.
However, cell processing instruments often require a significant upfront investment, along with ongoing maintenance and operational expenses, which can pose a barrier to adoption, especially for smaller research facilities and institutions with limited budgets. Thereby anticipated to hamper the growth of the market to a certain extent.
Based on type, the cell separator systems segment led the market with the largest revenue share of 22.25% in 2023. This system offers high precision & efficiency in isolating target cells from heterogeneous cell populations, thus, increasing the demand for the instrument in pharmaceutical & biotechnology companies. On the other hand, the cell imaging systems segment is expected to grow at the fastest CAGR over the forecast period
Based on application, the cell separation/isolation segment held the market with the largest revenue share of 35.30% in 2023. The diverse applications such as cancer research, immunotherapy, tissue engineering, and stem cell research are expected to propel the growth of the segment. On the other hand, the cell viability and proliferation segment is expected to grow at the fastest CAGR over the forecast period
Based on end-use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 41.13% in 2023. This is attributed to the growing R&D activities for drug discovery, increasing demand for personalized medicines, and growing technological advancements in cell therapy. On the other hand, the CROs & CMOs segment is anticipated to grow at the fastest CAGR over the forecast period
North America dominated the market with the revenue share of 36.22% in 2023, due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. The increasing demand for cell-based therapies
3.2.1.2. Rising incidence of chronic diseases
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of instruments
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Cell Processing Instruments Market: Type Business Analysis
4.1. Segment Dashboard
4.2. Global Cell Processing Instruments Market Type Movement Analysis
4.3. Global Cell Processing Instruments Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Cell Counters
4.4.1. Global Cell Counters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Cell Imaging Systems
4.5.1. Global Cell Imaging Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Flow Cytometers
4.6.1. Global Flow Cytometers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Cell Separator Systems
4.7.1. Global Cell Separator Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Automated Cell Processing Systems
4.8.1. Global Automated Cell Processing Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Other Instruments
4.9.1. Global Other Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Cell Processing Instruments Market: Application Business Analysis
5.1. Segment Dashboard
5.2. Global Cell Processing Instruments Market Application, Movement Analysis
5.3. Global Cell Processing Instruments Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cell Isolation/Separation
5.4.1. Global Cell Isolation/Separation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cell Imaging & Counting
5.5.1. Global Cell Imaging & Counting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Cell Viability & Proliferation
5.6.1. Global Cell Viability & Proliferation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Other Applications
5.7.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Cell Processing Instruments Market: End-use Business Analysis
6.1. Segment Dashboard
6.2. Global Cell Processing Instruments Market End-use Movement Analysis
6.3. Global Cell Processing Instruments Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. CROs & CMOs
6.5.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)